ACC 2019: Duration of Diabetes and Cardiorenal Efficacy of Liraglutide and Semaglutide

Published: 11 Apr 2019

  • Views:

    Views Icon 38
  • Likes:

    Heart Icon 1

Prof Subodh Verma (University of Toronto, Toronto, CA) discusses his poster presented at the ACC 2019 titled duration of diabetes and cardiorenal efficacy of liraglutide and semaglutide - a post hoc analysis of the LEADER and SUSTAIN-6 Clinical Trials

Filmed on site at ACC 2019 by Radcliffe Cardiology


Videography: Josh Birch

Interviewer: Liam O'Neill